Welcome To Nuvilex Inc HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Re: Is 68% Effectivity Worth Interest?

Apr 27, 2008 10:18AM

68% seems good to me but are we looking at approval for prescription or more of an over-the-counter product?

EFSF likes to put out NRs that do not mean that much but maintain the company in the public eye. Applauding the European.... should not make much of a difference, imo.

From the web site:

Citroxin
Citroxin is an environmentally safe product formulated entirely of food-grade components. In Environmental Protection Agency (EPA) required laboratory tests, Citroxin showed a 100% kill rate for the “big six” bacterial health threats as follows: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, as well as Avian Influenza and Black Mold.


Citroxin O2
Citroxin O2 is a fully ingestible formula of Citroxin. In independent laboratory testing Citroxin O2 was 100% successful in eradicating a strain of H95N avian influenza virus. The product is currently undergoing clinical testing to determine its efficacy in reducing the severity and duration of the effects of the influenza virus. Citroxin showed a 100% kill rate for the “big six” bacterial health threats as follows: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, as well as Avian Influenza and Black Mold.

... I think the market tells us this last news is a non-entity as the share price averaged .16 on Friday.

Nevertheless, efsf is worth holding.

go

Share
New Message
Please login to post a reply